# A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Article · Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco, Christopher Rodman, Mei-Ju Su, Johannes C. Melms, Rachel L. Leeson, Abhay Kanodia, Shaolin Mei, Jia‐Ren Lin, Shu Wang, Bokang Rabasha, David Liu, Gao Zhang, Claire Margolais, Orr Ashenberg, Patrick Alexander Ott, Elizabeth Iannotti Buchbinder, Rizwan Haq, Frank Stephen Hodi, Genevieve Marie Boland, Ryan Joseph Sullivan, Dennie Tompers Frederick, Benchun Miao, Tabea O. C. Moll and 27 more

- Archive id: doi:10.1016/j.cell.2018.09.006
- Published: 2018-11-01
- Venue: Cell
- DOI: https://doi.org/10.1016/j.cell.2018.09.006
- PMID: 30388455
- Citations: 1,428
- Source URL: https://doi.org/10.1016/j.cell.2018.09.006
- PDF: http://www.cell.com/article/S0092867418311784/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.